Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 129,418 | 158,617 | 150,880 | 166,728 | 210,647 |
| Marketable Securities | 65,485 | 78,468 | 107,182 | 126,146 | 155,683 |
| Receivables | 13,536 | 14,612 | 35,480 | 14,741 | 35,317 |
| Inventories | 25,418 | 24,170 | 42,125 | 20,744 | 42,644 |
| Other current assets | 230,676 | 223,089 | 0 | 42,963 | 0 |
| TOTAL | $472,439 | $506,037 | $344,019 | $375,883 | $453,607 |
| Non-Current Assets | |||||
| PPE Net | 20,738 | 22,678 | 43,593 | 22,775 | 41,982 |
| Investments And Advances | 19,485 | 0 | 0 | 0 | 17,949 |
| Intangibles | 0 | 0 | 139,776 | 0 | 129,709 |
| Other Non-Current Assets | 26,974 | 28,250 | 52,209 | 213,687 | 38,292 |
| TOTAL | $67,197 | $50,928 | $235,578 | $236,462 | $227,932 |
| Total Assets | $539,636 | $556,965 | $579,597 | $612,345 | $681,539 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,619 | 7,329 | 11,778 | 5,049 | 10,926 |
| Accrued Expenses | 30,810 | 24,207 | 21,972 | 21,435 | 31,686 |
| Other current liabilities | 22,214 | 17,984 | N/A | 20,804 | N/A |
| TOTAL | $107,965 | $98,024 | $56,236 | $65,895 | $120,615 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 43,209 | 43,410 | 16,152 | 13,801 | 16,968 |
| Other Non-Current Liabilities | 23,476 | 24,772 | 28,686 | 33,730 | 29,949 |
| TOTAL | $32,012 | $34,406 | $68,766 | $74,728 | $71,591 |
| Total Liabilities | $139,977 | $132,430 | $125,002 | $140,623 | $192,206 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 384,565 | 381,995 | 379,822 | 378,986 | 372,259 |
| Common Shares | 401 | 400 | 397 | 396 | 390 |
| Retained earnings | -1,279,830 | -1,245,143 | -1,211,684 | -1,185,651 | -1,151,579 |
| Other shareholders' equity | -944 | -2,395 | 702 | 758 | -1,876 |
| TOTAL | $399,659 | $424,535 | $454,595 | $471,722 | $489,333 |
| Total Liabilities And Equity | $539,636 | $556,965 | $579,597 | $612,345 | $681,539 |